10-QPeriod: Q2 FY2021

UNITEDHEALTH GROUP INC Quarterly Report for Q2 Ended Jun 30, 2021

Filed August 3, 2021For Securities:UNH

Summary

UnitedHealth Group (UNH) reported its second-quarter 2021 financial results, demonstrating robust revenue growth driven by both its UnitedHealthcare and Optum segments. Total revenues increased by 15% year-over-year to $71.3 billion, with UnitedHealthcare revenues up 13% and Optum revenues growing 17%. This growth was supported by an increase in the number of individuals served across Medicare Advantage and Medicaid programs, alongside expansion in Optum's care delivery and managed services. Despite strong revenue performance, earnings from operations saw a notable decline of 35% year-over-year to $6.0 billion. This was primarily attributed to the reduction in temporary care deferrals related to the COVID-19 pandemic, which, while easing, still impacted the comparison against the prior year when deferrals were more significant. Additionally, increased COVID-19 related care costs and rebate requirements also weighed on profitability. Diluted earnings per share decreased to $4.46 from $6.91 in the prior year's second quarter. The company also announced an increase in its quarterly cash dividend and continues to pursue strategic acquisitions, including the notable pending acquisition of Change Healthcare.

Financial Highlights

55 data points
Beta

Revenue

$71.32B

89.3% Gross Margin

Net Income

$4.27B

6.0% Net Margin

EPS (Diluted)

$4.46

Total Assets

$210.29B

Cash & Equivalents

$19.83B

Free Cash Flow

$4.98B

Financial Statements
Beta
Revenue$71.32B
Cost of Revenue$7.66B
Gross Profit$63.66B
SG&A Expenses$10.36B
Operating Expenses$65.34B
Operating Income$5.98B
Interest Expense$410.00M
Net Income$4.27B
EPS (Basic)$4.52
EPS (Diluted)$4.46
Shares Outstanding (Basic)944.00M
Shares Outstanding (Diluted)956.00M

Key Highlights

  • 1Total revenues surged 15% to $71.3 billion for the second quarter of 2021, indicating strong top-line growth.
  • 2UnitedHealthcare segment revenue increased by 13% year-over-year, driven by growth in Medicare Advantage and Medicaid enrollment.
  • 3Optum segment revenue grew by 17%, demonstrating strong performance across its various business lines.
  • 4Earnings from operations declined by 35% to $6.0 billion, largely due to the normalization of COVID-19 related care deferrals from the prior year's elevated levels.
  • 5Diluted EPS decreased to $4.46 from $6.91 in the prior year's second quarter, reflecting the impact of lower earnings from operations.
  • 6The company increased its quarterly cash dividend to an annual rate of $5.80 per share, signaling confidence in its financial stability and commitment to shareholder returns.
  • 7UnitedHealth Group is pursuing a significant acquisition of Change Healthcare, subject to regulatory approvals, which could reshape its market position.

Frequently Asked Questions

The decrease in earnings from operations was primarily due to the waning effects of temporary care deferrals related to the COVID-19 pandemic. In the prior year's second quarter, these deferrals significantly reduced medical costs, creating an easy comparison. As care utilization returned to more normal levels (and in some cases exceeded them due to pent-up demand), medical costs increased, leading to a year-over-year decrease in operating earnings despite higher revenues.

UnitedHealth Group acknowledges that COVID-19 continues to evolve and impact its business. While temporary care deferrals are decreasing, COVID-19 related care costs and other economic impacts persist. The company anticipates that increased consumer demand for care and continued COVID-19 related costs may lead to higher medical costs in future periods. They are focused on managing these trends through care cost management initiatives, consumer engagement, and adapting to changing care delivery models.

The pending acquisition of Change Healthcare, valued at approximately $9 billion, is a significant strategic move for UnitedHealth Group. Change Healthcare is a major player in healthcare technology and data analytics. This acquisition, if completed, is expected to enhance UnitedHealth Group's Optum segment by expanding its capabilities in areas like claims processing, network management, and data insights, potentially creating a more integrated and efficient healthcare ecosystem.

UnitedHealth Group is committed to returning capital to shareholders through both dividends and share repurchases. In June 2021, the company's Board of Directors increased the quarterly cash dividend to an annual rate of $5.80 per share, up from $5.00. Additionally, the company actively engages in share repurchases; in the first six months of 2021, they repurchased approximately 8 million shares. As of June 30, 2021, there was Board authorization for up to 50 million additional share repurchases.